Qlucore, a developer of bioinformatics software, has announced a licence contract with Cambridge Protein Arrays
Qlucore, a provider of bioinformatics visualization and analysis software, has launched the latest version of Qlucore Omics Explorer 3.4.
Qlucore and Nebion have started a collaboration to provide scientists with an end-to-end solution for gene expression analysis, by combining Qlucore Omics Explorer and Genevestigator into a single end to end software package
Rodin Therapeutics, a venture-backed biotechnology company that develops therapeutics for neurological disorders has announced that it uses Qlucore Omics Explorer to characterise its compounds response to treatment.
Qlucore, a provider of bioinformatics visualisation software, has announced the beta version of Qlucore Omics Explorer 3.3. This includes a completely new Next Generation Sequencing (NGS) Module, and range of new functionalities for the base version.
The NGS Module will enable additional functionality related to data generated with NGS technologies which will make it possible to dynamically visualise and analyse NGS data.
As part of its continued expansion into the US market Qlucore has announced the appointment of a new sales manager for the mid-Atlantic region, Beth Repetti.
Qlucore, a developer of bioinformatics software, has announced the launch of the Mac version of Qlucore Omics Explorer 3.1 data analysis software
Qlucore, a leader in the development of bioinformatics software, has announced a partnership with TATAA Biocenter, the world´s premier organizer of hands-on training in molecular diagnostics and Europe´s leading provider of genomic services
As the worlds 12th largest economy, South Korea is one of the fastest growing and most exciting markets in the world
In recent years, transcriptomic profiling via next generation sequencing (RNA-seq) has emerged as both a technical and cost-effective alternative to arrays
Elsevier and ExactCure recently announced a collaboration to develop and offer to hospitals – without charge – drug-specific exposure models for 20 already approved medicines that are being tested as potential treatments for Covid-19.
With the world’s focus on the COVID-19 pandemic, LIMS providers are working to develop solutions tailored to assist in the testing and management of virus samples.
Researchers at Harvard Medical School (HMS) have released an open source drug discovery platform, VirtualFlow, that harnesses supercomputing power to screen potentially billions of small organic compound structures in parallel, in the hunt for promising new drug molecules.
When designing a component or system, where do you start? In days gone by, designers would literally go back to the drawing board, using their experience and expertise to develop a new concept.
Effective utilisation of computing tools is critical to both AI and HPC research, with recent projects in both fields highlighting the scientific benefit of carefully managing resources.
Advances in computer vision combined with AI computing are helping pathologists to more accurately identify subtypes of cancer - leading to better treatments for patients, explains Dan Ruderman.
